CircRNA Circ-PDCD11 Promotes Triple-negative Breast Cancer Progression Via Enhancing Aerobic Glycolysis

Overview

Journal Cell Death Discov

Date 2021 Aug 22

PMID 34420029

Citations 21

Authors

Zeyu Xing

Ruojiao Wang

Xin Wang

Jiaqi Liu

Menglu Zhang

Kexin Feng

Xiang Wang

Affiliations

Soon will be listed here.

Abstract

Well-described evidence has demonstrated the critical roles of aerobic glycolysis in triple-negative breast cancer (TNBC) oncotherapy. Moreover, next-generation high-throughput sequencing indicates the potential regulation of energy metabolism by circular RNAs (circRNAs) in TNBC. However, circRNA modulation of TNBC aerobic glycolysis is still unclear. Here, the present research aimed to investigate the function and underlying mechanisms of novel circPDCD11 (hsa_circ_0019853) in TNBC aerobic glycolysis. The results revealed that circPDCD11 expression was significantly upregulated in TNBC tissues and cells. Clinical data demonstrated that the high expression of circPDCD11 was closely correlated with a poor prognosis and acted as an independent risk factor for TNBC prognosis. Functionally, in vitro gain- and loss-of-function experiments revealed that circPDCD11 accelerated glucose uptake, lactate production, ATP generation, and the extracellular acidification rate in TNBC cells. In vivo, circPDCD11 silencing repressed tumor growth. Mechanistically, circPDCD11 acted as a miRNA sponge to enhance LDHA expression by sponging miR-432-5p. In conclusion, these combined results demonstrated that circPDCD11 acts as an oncogene for TNBC, providing a promising prognostic biomarker for TNBC.

Citing Articles

Circular RNA pappalysin-1 enhances glycolysis via microRNA-656-3p targeting G-protein subunit gamma-5 to promote colon cancer progression.

Cai A, Ye H, Lin Y, Li J, Fang D, Pan Z Clinics (Sao Paulo). 2025; 80:100594.

PMID: 39951875 PMC: 11874721. DOI: 10.1016/j.clinsp.2025.100594.

The role of circRNA in breast cancer drug resistance.

Yang S, Li D PeerJ. 2024; 12:e18733.

PMID: 39713143 PMC: 11662897. DOI: 10.7717/peerj.18733.

Circ_0001741 exerts as a tumor promoter in ovarian cancer through the regulation of miR-491-5p/PRSS8 axis.

Wang D, Zhang S, Wang Q, Li P, Liu Y Discov Oncol. 2024; 15(1):643.

PMID: 39527152 PMC: 11554978. DOI: 10.1007/s12672-024-01474-3.

The therapeutic potential of circular RNA in triple-negative breast cancer.

Xu A, Zhu L, Yao C, Zhou W, Guan Z Cancer Drug Resist. 2024; 7:13.

PMID: 38835343 PMC: 11149105. DOI: 10.20517/cdr.2023.141.

Oncogenic role of RNA-binding protein GNL2 in glioma: Promotion of tumor development through enhancing protein synthesis.

Yang X, Li X Oncol Lett. 2024; 28(1):307.

PMID: 38779136 PMC: 11110002. DOI: 10.3892/ol.2024.14440.

References

Wang S, Li Q, Wang Y, Li X, Wang R, Kang Y . Upregulation of circ-UBAP2 predicts poor prognosis and promotes triple-negative breast cancer progression through the miR-661/MTA1 pathway. Biochem Biophys Res Commun. 2018; 505(4):996-1002. DOI: 10.1016/j.bbrc.2018.10.026. View

Marra A, Viale G, Curigliano G . Recent advances in triple negative breast cancer: the immunotherapy era. BMC Med. 2019; 17(1):90. PMC: 6507064. DOI: 10.1186/s12916-019-1326-5. View

Zhou L, Zhai M, Huang Y, Xu S, An T, Wang Y . The circular RNA ACR attenuates myocardial ischemia/reperfusion injury by suppressing autophagy via modulation of the Pink1/ FAM65B pathway. Cell Death Differ. 2018; 26(7):1299-1315. PMC: 6748144. DOI: 10.1038/s41418-018-0206-4. View

Chen B, Wei W, Huang X, Xie X, Kong Y, Dai D . circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression. Theranostics. 2018; 8(14):4003-4015. PMC: 6071524. DOI: 10.7150/thno.24106. View

Wang Y, Liu J, Ma J, Sun T, Zhou Q, Wang W . Exosomal circRNAs: biogenesis, effect and application in human diseases. Mol Cancer. 2019; 18(1):116. PMC: 6610963. DOI: 10.1186/s12943-019-1041-z. View

Lin J, Liao S, Li E, Liu Z, Zheng R, Wu X . circCYFIP2 Acts as a Sponge of miR-1205 and Affects the Expression of Its Target Gene E2F1 to Regulate Gastric Cancer Metastasis. Mol Ther Nucleic Acids. 2020; 21:121-132. PMC: 7286931. DOI: 10.1016/j.omtn.2020.05.007. View

Bardia A, Mayer I, Vahdat L, Tolaney S, Isakoff S, Diamond J . Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer. N Engl J Med. 2019; 380(8):741-751. DOI: 10.1056/NEJMoa1814213. View

Zeng K, He B, Yang B, Xu T, Chen X, Xu M . The pro-metastasis effect of circANKS1B in breast cancer. Mol Cancer. 2018; 17(1):160. PMC: 6240936. DOI: 10.1186/s12943-018-0914-x. View

Bach D, Lee S, Sood A . Circular RNAs in Cancer. Mol Ther Nucleic Acids. 2019; 16:118-129. PMC: 6411617. DOI: 10.1016/j.omtn.2019.02.005. View

10.

Garrido-Castro A, Lin N, Polyak K . Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment. Cancer Discov. 2019; 9(2):176-198. PMC: 6387871. DOI: 10.1158/2159-8290.CD-18-1177. View

11.

Yang R, Xing L, Zheng X, Sun Y, Wang X, Chen J . The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer. 2019; 18(1):4. PMC: 6325825. DOI: 10.1186/s12943-018-0933-7. View

12.

Kong Y, Yang L, Wei W, Lyu N, Zou Y, Gao G . CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression. Epigenomics. 2019; 11(10):1163-1176. DOI: 10.2217/epi-2019-0093. View

13.

Shi Y, Zhang Y, Ran F, Liu J, Lin J, Hao X . Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect. Cancer Lett. 2020; 495:53-65. DOI: 10.1016/j.canlet.2020.09.012. View

14.

Shen S, Yao T, Xu Y, Zhang D, Fan S, Ma J . CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc. Mol Cancer. 2020; 19(1):151. PMC: 7586679. DOI: 10.1186/s12943-020-01269-4. View

15.

Ye F, Gao G, Zou Y, Zheng S, Zhang L, Ou X . circFBXW7 Inhibits Malignant Progression by Sponging miR-197-3p and Encoding a 185-aa Protein in Triple-Negative Breast Cancer. Mol Ther Nucleic Acids. 2019; 18:88-98. PMC: 6796723. DOI: 10.1016/j.omtn.2019.07.023. View

16.

Xiao W, Zheng S, Zou Y, Yang A, Xie X, Tang H . CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1. Aging (Albany NY). 2019; 11(24):12043-12056. PMC: 6949091. DOI: 10.18632/aging.102539. View

17.

Dou D, Ren X, Han M, Xu X, Ge X, Gu Y . CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis. Cancer Cell Int. 2020; 20:454. PMC: 7491078. DOI: 10.1186/s12935-020-01547-7. View

18.

Yu T, Wang Y, Fan Y, Fang N, Wang T, Xu T . CircRNAs in cancer metabolism: a review. J Hematol Oncol. 2019; 12(1):90. PMC: 6727394. DOI: 10.1186/s13045-019-0776-8. View

19.

Chen Y, Yang F, Fang E, Xiao W, Mei H, Li H . Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes. Cell Death Differ. 2018; 26(7):1346-1364. PMC: 6748083. DOI: 10.1038/s41418-018-0220-6. View

20.

Tanaka T, Ikegami Y, Nakazawa H, Kuriyama N, Oki M, Hanai J . Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro. J Cell Physiol. 2016; 232(1):192-201. DOI: 10.1002/jcp.25411. View